A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
May 14, 2019
What We’re Watching: May 14, 2019
WE KEEP TALKING ABOUT RISK-BASED PAYMENT MODELS Last week, Premier and other groups called on HHS Secretary Alex Azar to improve and make permanent...
May 07, 2019
What We’re Watching: May 7, 2019
CMS recently announced the most significant movement from Medicare fee-for-service to date.
May 07, 2019
Benchmarking to Root Out Variation and Improve Quality of Care
To root out variation while maintaining or improving quality, successful health systems are proving that robust benchmarking analytics are essential.
April 30, 2019
What We’re Watching: April 30, 2019
Policymakers are calling on CMS and other federal agencies to step up efforts to address the rising rate of maternal mortality.
April 29, 2019
Is That a Bundle Behind Your ACO?
Shadow bundles use existing ACO attributed lives and claims data to align specialists, and provide an in-depth view of procedural or chronic disease opportunity.
April 26, 2019
Four Methods to Ensure Physicians are Engaged in Transformation Initiatives
While every healthcare organization’s culture is different, it’s difficult to imagine successfully navigating the complexity of industry change without physicians at the center.
April 25, 2019
Preparing for the Future with BPCI Advanced: Five Things to Know
The BPCI Advanced Model can be a great choice to help health systems achieve future success in a value-based care delivery environment.
April 23, 2019
What We’re Watching: April 23, 2019
CMS announced two new alternative payment models that are intended to move healthcare providers away from fee-for-service and toward value-based care.
April 22, 2019
Three Benefits to the Oncology Care Model & Four Recommendations to Advance It
The Oncology Care Model has shown promise but barriers exist to achieving optimal outcomes for both patients and providers.
April 16, 2019
What We’re Watching: April 16, 2019
A series of Congressional hearings to get to the bottom of high drug prices occurred last week.
April 15, 2019
Owning the Benefits of the Medicare Shared Savings Program
With looming deadlines afoot for a program that could mean future success or duress for health systems, here's what health systems should know.
April 09, 2019
What We’re Watching: April 9, 2019
CMS has finalized the CY20 Medicare Advantage (MA) rules and released the final MA and Part D flexibility rule for PY2020.
April 04, 2019
Three Successful Approaches to Gainsharing in Bundles
Now is the time to engage with physicians and post-acute care providers who deliver high-quality care and can help organizations achieve savings in bundles.
April 01, 2019
What We’re Watching: April 1, 2019
A new study of health system pharmacists found that two-thirds of those surveyed grapple with more than 50 drug shortages each year.
April 01, 2019
Don’t Forget to Look Beyond the ED for Sepsis Care
Part of the reason for its high cost and incidence is that sepsis can be tricky to diagnose. But hospitals are fighting the infection head-on.
March 28, 2019
Optimizing Value-Based Contracts in the Transition to Risk
Let’s explore the factors that must be weighed when determining financial targets and reimbursement rates in value-based contracts.
March 25, 2019
What We’re Watching: March 25, 2019
Premier President and CEO, Susan DeVore, appeared on Mornings with Maria on March 19.
March 24, 2019
Four Keys to Taking Workforce Management to the Next Level
Healthcare leaders need a bold approach to optimizing workforce spend within the framework of maintaining or improving care delivery.
March 18, 2019
What We’re Watching: March 18, 2019
Drug pricing continues to dominate the healthcare conversation.
March 17, 2019
The Five Elements of Optimal Care Delivery: Managing Patients Across Settings
Care progression is foundational to ensuring patients are equipped with the support and tools they need to participate in and improve their health.
March 12, 2019
What We’re Watching: March 12, 2019
Drug pricing hearings continue to command attention from the Congressional healthcare committees.
